For other countries, any question or an interest in distributing OncoDEEP in your country please contact us at email@example.com
Thank you to Servier Medical Art for the graphic elements: http://servier .fr/smart/banque-dimages-powerpoint
Our solution OncoSTRAT&GO is the only one on the market that combines, in a single analysis, the profiling of a solid biopsy and of a liquid biopsy. The solid biopsy consists in a small piece of the primary tumor or of metastasis while the liquid biopsy is a simple blood sample.
The aim of analyzing the solid tumor is to steer oncologists towards new treatment options based on the complete molecular profiling of the tumor, meaning not just the analysis of the DNA, the genetic material of the tumor but also the analysis of crucial protein biomarker. Why ? Simply because not all info is written in the DNA. The analysis of the blood sample monitors the progression of a patient's tumor and assesses treatment effectiveness.
OncoDNA provides multiples solutions for the right cancer approach and cancer treatment
The unique personalized non-invasive blood based solution to monitor the evolution of the tumor and the effectiveness of the treatment.Learn more
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.